Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Drug Safety
|
March 1, 1992
Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate)
K S Eyres, P Marshall, E McCloskey, et al.
Metabolic Bone Disease & Related Research
|
January 1, 1981
Effects of 24,25-dihydroxy-vitamin D3 on its plasma level in man
J A Kanis, C M Taylor, D L Douglas, et al.
The Journal of Bone and Joint Surgery. British Volume
|
January 1, 1990
Improvement in the deformity of the face in Paget's disease treated with diphosphonates
D R Bickerstaff, D L Douglas, P H Burke, et al.
Journal of Clinical Pathology
|
July 1, 1982
Ultrastructural features of the osteoclasts from Paget's disease of bone in relation to a viral aetiology
L Harvey, T Gray, M N Beneton, et al.
Spinal Cord
|
February 27, 2001
Neurological deterioration years after closure of myelomeningocoele - 'the second lesion'
D C Macarthur, J A Punt, M Spencer, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1980
Response of red cell phosphate to acute and chronic changes in plasma phosphate in man
C J Preston, A Challa, J E Phillips, et al.
The Journal of Bone and Joint Surgery. British Volume
|
January 1, 1981
Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis?
D L Douglas, T Duckworth, J A Kanis, et al.
Metabolic Bone Disease & Related Research
|
January 1, 1981
Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitonin
D L Douglas, J A Kanis, T Duckworth, et al.
British Journal of Haematology
|
May 1, 1983
The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma
A D Paterson, J A Kanis, E C Cameron, et al.
Clinical Endocrinology
|
April 1, 1985
Abnormal vitamin D metabolism in Paget's disease of bone
D F Guillard-Cumming, D J Beard, D L Douglas, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Drug Safety
|
March 1, 1992
Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate)
K S Eyres, P Marshall, E McCloskey, et al.
Metabolic Bone Disease & Related Research
|
January 1, 1981
Effects of 24,25-dihydroxy-vitamin D3 on its plasma level in man
J A Kanis, C M Taylor, D L Douglas, et al.
The Journal of Bone and Joint Surgery. British Volume
|
January 1, 1990
Improvement in the deformity of the face in Paget's disease treated with diphosphonates
D R Bickerstaff, D L Douglas, P H Burke, et al.
Journal of Clinical Pathology
|
July 1, 1982
Ultrastructural features of the osteoclasts from Paget's disease of bone in relation to a viral aetiology
L Harvey, T Gray, M N Beneton, et al.
Spinal Cord
|
February 27, 2001
Neurological deterioration years after closure of myelomeningocoele - 'the second lesion'
D C Macarthur, J A Punt, M Spencer, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1980
Response of red cell phosphate to acute and chronic changes in plasma phosphate in man
C J Preston, A Challa, J E Phillips, et al.
The Journal of Bone and Joint Surgery. British Volume
|
January 1, 1981
Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis?
D L Douglas, T Duckworth, J A Kanis, et al.
Metabolic Bone Disease & Related Research
|
January 1, 1981
Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitonin
D L Douglas, J A Kanis, T Duckworth, et al.
British Journal of Haematology
|
May 1, 1983
The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma
A D Paterson, J A Kanis, E C Cameron, et al.
Clinical Endocrinology
|
April 1, 1985
Abnormal vitamin D metabolism in Paget's disease of bone
D F Guillard-Cumming, D J Beard, D L Douglas, et al.
Page
of 4